FDA Brief

Warning letters Animal

FDA warning letter to

Groupe Cyrenne Inc. dba HomeoAnimal

High riskIssued Apr 8, 2021Posted Apr 27, 2021Center for Veterinary Medicine

FDA warned HomeoAnimal that it sells unapproved animal drugs with claims to treat cancer, heartworm, seizures, and COVID-19 in animals.

What happened

FDA reviewed HomeoAnimal’s website from December 2020 through March 2021 and its Facebook page. FDA found the company took orders for many animal products and claimed they cure, mitigate, treat, or prevent diseases in animals, including coronavirus/COVID-19 claims for a Virus Defense Kit. FDA said these products are unapproved new animal drugs, meaning drugs that need FDA approval before they can be sold.

What FDA found

  1. The website claims the products treat or prevent diseases in animals, which makes them drugs under the law.

    FD&C Act section 201(g)(1)(B) [21 U.S.C. § 321(g)(1)(B)]
  2. The products are new animal drugs because they are not generally recognized as safe and effective for their labeled uses.

    FD&C Act section 201(v) [21 U.S.C. § 321(v)]
  3. The products are not FDA-approved or index listed, so FDA considers them unsafe.

    FD&C Act section 512(a) [21 U.S.C. § 360b(a)]
  4. Because they are unapproved, FDA calls the products adulterated.

    FD&C Act section 501(a)(5) [21 U.S.C. § 351(a)(5)]
  5. Selling or shipping these products in interstate commerce is prohibited.

    FD&C Act section 301(a) [21 U.S.C. § 331(a)]

What FDA wants

FDA tells HomeoAnimal to take immediate action to stop selling unapproved products that claim to mitigate, prevent, treat, diagnose, or cure COVID-19. The company must notify FDA in writing within 15 working days of steps taken to correct the violations, or explain any delay and give a completion date.

Who should pay attention

  • veterinarians and pet owners who buy online animal remedies
  • animal supplement and homeopathic product sellers making disease claims
  • online marketplaces and social media platforms hosting such claims

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. AHC Products, Inc.

    AHC Products, Inc. was cited for manufacturing-rule violations and unapproved animal drugs, including AniPrin and Rot-B-Gone.

    High risk
  2. The Fish Aid

    FDA warned The Fish Aid it sells unapproved, unlisted antibiotics for aquarium fish and birds without veterinary oversight.

    High risk
  3. DK Hardware Supply

    FDA warns DK Hardware Supply over unapproved, unlisted aquarium-fish antibiotic drugs.

    High risk
  4. Synergy Animal Products, Inc.

    Synergy Animal Products marketed unapproved animal drugs for dairy cows with inadequate directions and major manufacturing violations.

    High risk